Press Releases 2016

Biocon Biologics  /  Press Releases  /  Press Releases 2016

Journal of the American Medical Association (JAMA) Publishes Mylan and Biocon’s Proposed Biosimilar Trastuzumab Phase 3 Data

  • Posted by: Biocon Biologics

Biocon Features in Asia IP Elite 2016 List

  • Posted by: Biocon Biologics

Biocon’s Novel Diabetes Education Initiative for Medical Practitioners ‘ABIDE’ Awarded by RSSDI

  • Posted by: Biocon Biologics

Biocon Collaborates with Healthcare Professionals for a Public Awareness Campaign on Diabetes Prevention & Management Across India

  • Posted by: Biocon Biologics

Mylan and Biocon Announce U.S. FDA Submission for Proposed Biosimilar Trastuzumab

  • Posted by: Biocon Biologics

Mylan and Biocon Announce Regulatory Submission for Insulin Glargine Accepted for Review by European Medicines Agency

  • Posted by: Biocon Biologics

Biocon Ranked Among Global Top Ten Biotech Employers; The only Asian Company to Feature in 2016 Rankings Biocon moves up to No. 9 from No. 13 last year

  • Posted by: Biocon Biologics

Biocon Q2 FY17 Revenue Up 21%; EBITDA Up 45%; Revenues at Rs 992 Crs.; EBITDA at Rs 277 Crs.; Net Profit at Rs 147 Crs.

  • Posted by: Biocon Biologics

Kiran Mazumdar Shaw Appointed ‘Knight of the Legion of Honour’ by the Government of France

  • Posted by: Biocon Biologics

Mylan & Biocon Announce Regulatory Submission for Proposed Biosimilar Pegfilgrastim Accepted for Review by European Medicines Agency

  • Posted by: Biocon Biologics
  • 1
  • 2
Share